Investor Svlsf V, Llc
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Svlsf V, Llc . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2021-08-16 13D/A BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock) 1,915,274 1,562,451
2019-06-07 13D BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock) 1,915,274
2018-10-09 13D STRO / Sutro Biopharma, Inc. 942,789
2018-02-14 13D XFOR / X4 Pharmaceuticals, Inc. 946,769
2017-02-07 13D/A ATXS / Astria Therapeutics, Inc. 2,857,667 2,857,667
2015-07-08 13D ATXS / Astria Therapeutics, Inc. 2,857,667